Anxiety

Psychiatry·MeSH: Anxiety Disorders

Prevalence

6090.6 / 100K

Incidence

716.2 / 100K/yr

42 drugs in development·32 companies·52 clinical trials

Drug Pipeline by Phase

Approved(6)

Drug	Company
buspirone	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
Cymbalta®	ELI LILLY & Co (LLY)
duloxetine	Inventiva S.A. (IVA)
lorazepam	ANI PHARMACEUTICALS INC (ANIP)
paroxetine	Mylan II B.V. (MYL)
paroxetine	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)

Phase 3(7)

Drug	Company
bnc210	Neuphoria Therapeutics Inc. (NEUP)
dt120	Definium Therapeutics Inc. (DFTX)
effexor sr	Viatris Inc (VTRS)
fasedienol	Vistagen Therapeutics, Inc. (VTGN)
ITI-1284-ODT-SL	Intra-Cellular Therapies, Inc. (ITCI)
MM-120	Definium Therapeutics Inc. (DFTX)
vqw-765	Vanda Pharmaceuticals Inc. (VNDA)

Phase 2(14)

Drug	Company
antidepressant therapy	AbbVie Inc. (ABBV)
cyb004	CYBIN INC. (HELP)
darigabat	Cerevel Therapeutics Holdings, Inc. (CERE)
EMP-01	Atai Beckley N.V. (ATAI)
EMP-01	Akari Therapeutics Plc (AKTX)
ENX-102	Valneva SE (VALN)
fasedienol nasal spray - fasedienol	Vistagen Therapeutics, Inc. (VTGN)
Fluoxetine	Valneva SE (VALN)
iti-1284	Intra-Cellular Therapies, Inc. (ITCI)
ITI-1549	Intra-Cellular Therapies, Inc. (ITCI)
MM120	Definium Therapeutics Inc. (DFTX)
ph94b	Vistagen Therapeutics, Inc. (VTGN)
Psilly	AIBOTICS, INC. (AIBT)
psx-001	Incannex Healthcare Inc. (IXHL)

Phase 1(2)

Drug	Company
ABBV-932	AbbVie Inc. (ABBV)
ART26.12	ARTELO BIOSCIENCES, INC. (ARTL)

Preclinical(10)

Drug	Company
ART12.11	ARTELO BIOSCIENCES, INC. (ARTL)
cannabis oil	ALGAE DYNAMICS CORP. (ADYNF)
curefilm central nervous system	AVENIR WELLNESS SOLUTIONS, INC. (CURR)
kar-2618	Karuna Therapeutics, Inc. (KRTX)
loxapine oral film	INTELGENX TECHNOLOGIES CORP. (IGXT)
nhāler	Rapid Therapeutic Science Laboratories, Inc. (RTSL)
phoenix mood	Phoenix Life Sciences International Limited. (PLSI)
prana bio nutrient medicinals	UNITED CANNABIS CORP (CNAB)
SPC-15	Silo Pharma, Inc. (SILO)
supera-cbd	Q/C TECHNOLOGIES, INC. (QCLS)

Unknown(3)

BioSniper tracks 42 drugs in development for Anxiety across 32 companies.

There are 52 clinical trials targeting Anxiety tracked by BioSniper.

The estimated prevalence of Anxiety is approximately 6090.6 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.